Showing results (151-160 of 302) with videos related to
Sort By:
Pageof 31
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2008
MDM2 promoter polymorphism and pancreatic cancer risk and prognosisKofi Asomaning, Amy E Reid, Wei Zhou, et al.International Journal of Radiation Oncology, Biology, Physics|June 5, 2007
Dosimetric feasibility of hypofractionated proton radiotherapy for neoadjuvant pancreatic cancer treatmentKevin R Kozak, Lisa A Kachnic, Judith Adams, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 21, 2022
Neoadjuvant Chemotherapy Is Associated with Altered Immune Cell Infiltration and an Anti-Tumorigenic Microenvironment in Resected Pancreatic CancerAndressa Dias Costa, Sara A Väyrynen, Akhil Chawla, et al.European Radiology|October 13, 2021
Response prediction of neoadjuvant chemoradiation therapy in locally advanced rectal cancer using CT-based fractal dimension analysisToru Tochigi, Sophia C Kamran, Anushri Parakh, et al.International Journal of Radiation Oncology, Biology, Physics|April 28, 2010
Phase I study of preoperative short-course chemoradiation with proton beam therapy and capecitabine for resectable pancreatic ductal adenocarcinoma of the headTheodore S Hong, David P Ryan, Lawrence S Blaszkowsky, et al.Journal of Gastrointestinal Cancer|April 14, 2019
Sexual Function, Quality of Life, and Mood After Radiation Therapy in Patients with Anal CancerDivya Yerramilli, Lorraine Drapek, Ryan D Nipp, et al.Cancer|January 30, 2002
A Phase II study of gemcitabine and docetaxel in patients with metastatic pancreatic carcinomaDavid P Ryan, Matthew H Kulke, Charles S Fuchs, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2007
Capecitabine plus erlotinib in gemcitabine-refractory advanced pancreatic cancerMatthew H Kulke, Lawrence S Blaszkowsky, David P Ryan, et al.Cancer|October 13, 2006
Phase I clinical trial of bortezomib in combination with gemcitabine in patients with advanced solid tumorsDavid P Ryan, Leonard J Appleman, Thomas Lynch, et al.British Journal of Cancer|October 6, 2017
Lymph node metastases in resected pancreatic ductal adenocarcinoma: predictors of disease recurrence and survivalVicente Morales-Oyarvide, Douglas A Rubinson, Richard F Dunne, et al.Pageof 31